Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.

Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2019 Aug;144(2):524-535.e8. doi: 10.1016/j.jaci.2018.10.064. Epub 2018 Dec 7.

PMID:
30529242
2.

New data in causes of autoinflammatory diseases.

Kone-Paut I, Georgin-Laviallec S, Galeotti C, Rossi-Semerano L, Hentgen V, Savey L, Saadoun D, Sarrabay G, Touitou I.

Joint Bone Spine. 2018 Nov 22. pii: S1297-319X(18)30426-3. doi: 10.1016/j.jbspin.2018.11.003. [Epub ahead of print]

PMID:
30471422
3.

Regulatory T cells induce activation rather than suppression of human basophils.

Sharma M, Das M, Stephen-Victor E, Galeotti C, Karnam A, Maddur MS, Bruneval P, Kaveri SV, Bayry J.

Sci Immunol. 2018 May 25;3(23). pii: eaan0829. doi: 10.1126/sciimmunol.aan0829.

PMID:
29802207
4.

Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.

Antonelli A, D'Andrea MM, Brenciani A, Galeotti CL, Morroni G, Pollini S, Varaldo PE, Rossolini GM.

J Antimicrob Chemother. 2018 Jul 1;73(7):1763-1769. doi: 10.1093/jac/dky088.

PMID:
29635422
5.

Boundaries between familial Mediterranean fever and juvenile spondyloarthritis: Analysis of three French retrospective cohorts.

Cherqaoui B, Rossi-Semerano L, Georgin-Lavialle S, Dusser P, Galeotti C, Piram M, Hentgen V, Touitou I, Koné-Paut I.

Joint Bone Spine. 2018 Dec;85(6):733-739. doi: 10.1016/j.jbspin.2018.01.010. Epub 2018 Feb 13.

PMID:
29452306
6.

An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin.

Cannatelli A, Giani T, Aiezza N, Di Pilato V, Principe L, Luzzaro F, Galeotti CL, Rossolini GM.

Sci Rep. 2017 Jul 11;7(1):5071. doi: 10.1038/s41598-017-05167-6.

7.

IVIG-mediated effector functions in autoimmune and inflammatory diseases.

Galeotti C, Kaveri SV, Bayry J.

Int Immunol. 2017 Dec 30;29(11):491-498. doi: 10.1093/intimm/dxx039. Review.

PMID:
28666326
8.

Demystification of enigma on antigen-presenting cell features of human basophils: data from secondary lymphoid organs.

Stephen-Victor E, Das M, Sharma M, Galeotti C, Fohrer-Ting H, Sendid B, Darnige L, Terris B, Badoual C, Bruneval P, Kaveri SV, Bayry J.

Haematologica. 2017 Jun;102(6):e233-e237. doi: 10.3324/haematol.2016.163451. Epub 2017 Feb 16. No abstract available.

9.

Human basophils may not undergo modulation by DC-SIGN and mannose receptor-targeting immunotherapies due to absence of receptors.

Das M, Galeotti C, Stephen-Victor E, Karnam A, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2017 Apr;139(4):1403-1404.e1. doi: 10.1016/j.jaci.2016.09.062. Epub 2017 Jan 11. No abstract available.

PMID:
28088336
10.

Familial and syndromic lupus share the same phenotype as other early-onset forms of lupus.

Weill O, Decramer S, Malcus C, Kassai B, Rouvet I, Ginhoux T, Crow YJ, Rieux-Laucat F, Soulas-Sprauel P, Pagnier A, Koné-Paut I, Piram M, Galeotti C, Samaille C, Reumaux H, Lanteri A, Dubois SM, Lefebvre H, Burtey S, Maurier F, Carbasse A, Lemelle I, Meinzer U, Despert V, Flodrops H, Fabien N, Ranchin B, Hachulla E, Bader-Meunier B, Belot A.

Joint Bone Spine. 2017 Oct;84(5):589-593. doi: 10.1016/j.jbspin.2016.12.008. Epub 2016 Dec 28.

PMID:
28039062
11.

IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis.

Stephen-Victor E, Sharma VK, Das M, Karnam A, Saha C, Lecerf M, Galeotti C, Kaveri SV, Bayry J.

Front Immunol. 2016 Nov 4;7:465. eCollection 2016.

12.

[Mevalonate kinase deficiency in 2016].

Galeotti C, Georgin-Lavialle S, Sarrabay G, Touitou I, Koné-Paut I.

Rev Med Interne. 2018 Apr;39(4):265-270. doi: 10.1016/j.revmed.2016.08.019. Epub 2016 Sep 19. French.

PMID:
27659743
13.

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease.

Galeotti C, Kaveri SV, Cimaz R, Koné-Paut I, Bayry J.

Drug Discov Today. 2016 Nov;21(11):1850-1857. doi: 10.1016/j.drudis.2016.08.004. Epub 2016 Aug 6. Review.

PMID:
27506874
14.

Zn2+ Uptake in Streptococcus pyogenes: Characterization of adcA and lmb Null Mutants.

Tedde V, Rosini R, Galeotti CL.

PLoS One. 2016 Mar 31;11(3):e0152835. doi: 10.1371/journal.pone.0152835. eCollection 2016.

15.

Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.

Galeotti C, Hegde P, Das M, Stephen-Victor E, Canale F, Muñoz M, Sharma VK, Dimitrov JD, Kaveri SV, Bayry J.

Sci Rep. 2016 Jan 22;6:19592. doi: 10.1038/srep19592.

16.

Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.

Koné-Paut I, Galeotti C.

Expert Rev Clin Immunol. 2015;11(10):1083-92. doi: 10.1586/1744666X.2015.1077702. Epub 2015 Aug 27. Review.

PMID:
26312542
17.

Recommendations for the management of autoinflammatory diseases.

ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, Cantarini L, Galeotti C, Grateau G, Hentgen V, Hofer M, Kallinich T, Kone-Paut I, Lachmann HJ, Ozdogan H, Ozen S, Russo R, Simon A, Uziel Y, Wouters C, Feldman BM, Vastert SJ, Wulffraat NM, Benseler SM, Frenkel J, Gattorno M, Kuemmerle-Deschner JB.

Ann Rheum Dis. 2015 Sep;74(9):1636-44. doi: 10.1136/annrheumdis-2015-207546. Epub 2015 Jun 24. Review.

18.

Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey.

Rossi-Semerano L, Fautrel B, Wendling D, Hachulla E, Galeotti C, Semerano L, Touitou I, Koné-Paut I; MAIL1 (Maladies Auto-inflammatoires et Anti-IL-1) study Group on behalf of CRI (Club Rhumatisme et Inflammation).

Orphanet J Rare Dis. 2015 Feb 15;10:19. doi: 10.1186/s13023-015-0228-7.

19.

Molecular and immunological biomarkers to predict IVIg response.

Galeotti C, Kaveri SV, Bayry J.

Trends Mol Med. 2015 Mar;21(3):145-7. doi: 10.1016/j.molmed.2015.01.005. Epub 2015 Feb 10.

PMID:
25680699
20.

A restrospective survey of patients's journey before the diagnosis of mevalonate kinase deficiency.

Berody S, Galeotti C, Koné-Paut I, Piram M.

Joint Bone Spine. 2015 Jul;82(4):240-4. doi: 10.1016/j.jbspin.2014.12.011. Epub 2015 Feb 9.

PMID:
25677409
21.

[Value of whole-body MRI in vertebral fractures].

Galeotti C, Tatencloux S, Adamsbaum C, Koné-Paut I.

Arch Pediatr. 2015 Mar;22(3):279-82. doi: 10.1016/j.arcped.2014.11.021. Epub 2015 Jan 30. French.

PMID:
25650082
22.

Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever.

Giancane G, Ter Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen V, Kallinich T, Ozdogan H, Anton J, Brogan P, Cantarini L, Frenkel J, Galeotti C, Gattorno M, Grateau G, Hofer M, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Simon A, Demirkaya E, Feldman B, Uziel Y, Ozen S.

Ann Rheum Dis. 2015 Apr;74(4):635-41. doi: 10.1136/annrheumdis-2014-206844. Epub 2015 Jan 27. Review.

23.

[Tocilizumab: experience in a French rheumatological pediatric center].

Le Stradic C, Galeotti C, Koné-Paut I.

Arch Pediatr. 2014 Dec;21(12):1299-304. doi: 10.1016/j.arcped.2014.08.018. Epub 2014 Oct 2. French.

PMID:
25282455
24.

How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients.

Galeotti C, Courtois E, Carbajal R.

Acta Paediatr. 2014 Dec;103(12):e548-54. doi: 10.1111/apa.12773. Epub 2014 Oct 2.

PMID:
25130719
25.

Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection.

Lanternier F, Barbati E, Meinzer U, Liu L, Pedergnana V, Migaud M, Héritier S, Chomton M, Frémond ML, Gonzales E, Galeotti C, Romana S, Jacquemin E, Angoulvant A, Bidault V, Canioni D, Lachenaud J, Mansouri D, Mahdaviani SA, Adimi P, Mansouri N, Jamshidi M, Bougnoux ME, Abel L, Lortholary O, Blanche S, Casanova JL, Picard C, Puel A.

J Infect Dis. 2015 Apr 15;211(8):1241-50. doi: 10.1093/infdis/jiu412. Epub 2014 Jul 23.

26.

Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis.

Lefèvre-Utile A, Galeotti C, Koné-Paut I.

Joint Bone Spine. 2014 May;81(3):257-9. doi: 10.1016/j.jbspin.2013.09.004. Epub 2014 May 1.

PMID:
24793086
27.

Anakinra for cryopyrin-associated periodic syndrome.

Koné-Paut I, Galeotti C.

Expert Rev Clin Immunol. 2014 Jan;10(1):7-18. doi: 10.1586/1744666X.2014.861325. Epub 2013 Nov 21. Review.

PMID:
24308832
28.

The expanding spectrum of rare monogenic autoinflammatory diseases.

Touitou I, Galeotti C, Rossi-Semerano L, Hentgen V, Piram M, Koné-Paut I; CeRéMAI, French reference center for autoinflammatory diseases.

Orphanet J Rare Dis. 2013 Oct 16;8:162. doi: 10.1186/1750-1172-8-162. Review.

29.

Diversity of cwp loci in clinical isolates of Clostridium difficile.

Biazzo M, Cioncada R, Fiaschi L, Tedde V, Spigaglia P, Mastrantonio P, Pizza M, Barocchi MA, Scarselli M, Galeotti CL.

J Med Microbiol. 2013 Sep;62(Pt 9):1444-52. doi: 10.1099/jmm.0.058719-0. Epub 2013 May 30.

PMID:
23722432
30.

[Management of monoarthritis in children].

Galeotti C, Koné-Paut I.

Arch Pediatr. 2012 Dec;19(12):1374-8. doi: 10.1016/j.arcped.2012.08.026. Epub 2012 Sep 27. French.

PMID:
23021629
31.

Longitudinal evaluation of the hypothalamic-pituitary-testicular function in 8 boys with adrenal hypoplasia congenita (AHC) due to NR0B1 mutations.

Galeotti C, Lahlou Z, Goullon D, Sarda-Thibault H, Cahen-Varsaux J, Bignon-Topalovic J, Bashamboo A, McElreavey K, Brauner R.

PLoS One. 2012;7(6):e39828. doi: 10.1371/journal.pone.0039828. Epub 2012 Jun 27.

32.

Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.

Galeotti C, Meinzer U, Quartier P, Rossi-Semerano L, Bader-Meunier B, Pillet P, Koné-Paut I.

Rheumatology (Oxford). 2012 Oct;51(10):1855-9. Epub 2012 Jun 26.

PMID:
22740624
33.

Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody.

Galeotti C, Boucheron A, Guillaume S, Koné-Paut I.

Mol Cancer Ther. 2012 Aug;11(8):1623-6. doi: 10.1158/1535-7163.MCT-11-0972. Epub 2012 May 25.

34.

Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide.

Adamo R, Romano MR, Berti F, Leuzzi R, Tontini M, Danieli E, Cappelletti E, Cakici OS, Swennen E, Pinto V, Brogioni B, Proietti D, Galeotti CL, Lay L, Monteiro MA, Scarselli M, Costantino P.

ACS Chem Biol. 2012 Aug 17;7(8):1420-8. doi: 10.1021/cb300221f. Epub 2012 Jun 7.

PMID:
22620974
35.

Surface interactome in Streptococcus pyogenes.

Galeotti CL, Bove E, Pezzicoli A, Nogarotto R, Norais N, Pileri S, Lelli B, Falugi F, Balloni S, Tedde V, Chiarot E, Bombaci M, Soriani M, Bracci L, Grandi G, Grifantini R.

Mol Cell Proteomics. 2012 Apr;11(4):M111.015206. doi: 10.1074/mcp.M111.015206. Epub 2011 Dec 22.

36.

The LMW surface-layer proteins of Clostridium difficile PCR ribotypes 027 and 001 share common immunogenic properties.

Spigaglia P, Galeotti CL, Barbanti F, Scarselli M, Van Broeck J, Mastrantonio P.

J Med Microbiol. 2011 Aug;60(Pt 8):1168-73. doi: 10.1099/jmm.0.029710-0. Epub 2011 Feb 24.

PMID:
21349988
37.

Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus.

Rinaudo CD, Rosini R, Galeotti CL, Berti F, Necchi F, Reguzzi V, Ghezzo C, Telford JL, Grandi G, Maione D.

PLoS One. 2010 Feb 15;5(2):e9216. doi: 10.1371/journal.pone.0009216.

38.

Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

Galeotti C, Bayry J, Kone-Paut I, Kaveri SV.

Autoimmun Rev. 2010 Apr;9(6):441-8. doi: 10.1016/j.autrev.2009.12.004. Epub 2010 Jan 13. Review.

PMID:
20004744
39.

BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.

Santi I, Maione D, Galeotti CL, Grandi G, Telford JL, Soriani M.

J Infect Dis. 2009 Aug 15;200(4):564-70. doi: 10.1086/603540.

PMID:
19586417
40.

[Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution].

Galeotti C, Maddur MS, Kazatchkine MD, Mouthon L, Kaveri SV.

Transfus Clin Biol. 2009 May;16(2):75-9. doi: 10.1016/j.tracli.2009.03.009. Epub 2009 May 13. Review. French.

PMID:
19443254
41.

IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.

Galeotti C, Tran TA, Franchi-Abella S, Fabre M, Pariente D, Koné-Paut I.

J Pediatr Hematol Oncol. 2008 Dec;30(12):920-4. doi: 10.1097/MPH.0b013e31818ab31f.

PMID:
19131781
42.

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm.

Margarit I, Rinaudo CD, Galeotti CL, Maione D, Ghezzo C, Buttazzoni E, Rosini R, Runci Y, Mora M, Buccato S, Pagani M, Tresoldi E, Berardi A, Creti R, Baker CJ, Telford JL, Grandi G.

J Infect Dis. 2009 Jan 1;199(1):108-15. doi: 10.1086/595564.

PMID:
19086816
43.

A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype.

Genisset C, Galeotti CL, Lupetti P, Mercati D, Skibinski DA, Barone S, Battistutta R, de Bernard M, Telford JL.

Infect Immun. 2006 Mar;74(3):1786-94.

44.
45.

New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B.

Di Giaimo R, Riccio M, Santi S, Galeotti C, Ambrosetti DC, Melli M.

Hum Mol Genet. 2002 Nov 1;11(23):2941-50.

PMID:
12393805
46.

Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.

Buonamassa DT, Greer CE, Capo S, Yen TS, Galeotti CL, Bensi G.

Virology. 2002 Feb 15;293(2):335-44.

47.

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Pizza M, Scarlato V, Masignani V, Giuliani MM, Aricò B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R.

Science. 2000 Mar 10;287(5459):1816-20.

48.

Comparison of secretion of a hepatitis C virus glycoprotein in Saccharomyces cerevisiae and Kluyveromyces lactis.

Mustilli AC, Izzo E, Houghton M, Galeotti CL.

Res Microbiol. 1999 Apr;150(3):179-87.

PMID:
10229947
50.

Supplemental Content

Loading ...
Support Center